These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 24652129)

  • 1. [Recommendations for smoking cessation in Colombia].
    Alba LH; Murillo R; Becerra N; Páez N; Cañas A; Mosquera C; Castillo JS; Camacho N; Gómez J; García-Herreros P; Bernal LG
    Biomedica; 2013; 33(2):186-204. PubMed ID: 24652129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy and safety of medication use for the cessation of tobacco addiction: A review of Clinical Practice Guidelines].
    Cañas A; Alba LH; Becerra N; Murillo R; Páez N; Mosquera C
    Rev Salud Publica (Bogota); 2014; 16(5):772-85. PubMed ID: 26120760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Counseling interventions for smoking cessation: systematic review].
    Alba LH; Murillo R; Castillo JS;
    Salud Publica Mex; 2013 Apr; 55(2):196-206. PubMed ID: 23546412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Alternative therapies for smoking cessation: clinical practice guidelines review].
    Astrid Becerra N; Alba LH; Castillo JS; Murillo R; Cañas A; García-Herreros P
    Gac Med Mex; 2012; 148(5):457-66. PubMed ID: 23128887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness analysis of varenicline versus existing smoking cessation strategies in Central America and the Caribbean using the BENESCO model.
    Lutz MA; Lovato P; Cuesta G
    Hosp Pract (1995); 2012 Feb; 40(1):24-34. PubMed ID: 22406880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of varenicline versus bupropion, nicotine-replacement therapy, and unaided cessation in Greece.
    Athanasakis K; Igoumenidis M; Karampli E; Vitsou E; Sykara G; Kyriopoulos J
    Clin Ther; 2012 Aug; 34(8):1803-14. PubMed ID: 22818870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost analysis of varenicline versus bupropion, nicotine replacement therapy, and unaided cessation in Nicaragua.
    Lutz MA; Lovato P; Cuesta G
    Hosp Pract (1995); 2012 Feb; 40(1):35-43. PubMed ID: 22406881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Costs and benefits of smoking cessation aids: making a case for public reimbursement of nicotine replacement therapy in Australia.
    Bertram MY; Lim SS; Wallace AL; Vos T
    Tob Control; 2007 Aug; 16(4):255-60. PubMed ID: 17652241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abstinence rates and predictors of outcome for smoking cessation: do Brazilian smokers need special strategies?
    Chatkin JM; Mariante de Abreu C; Haggsträm FM; Wagner MB; Fritscher CC
    Addiction; 2004 Jun; 99(6):778-84. PubMed ID: 15139876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smoking cessation: How compelling is the evidence? A review.
    Tønnesen P
    Health Policy; 2009 Jul; 91 Suppl 1():S15-25. PubMed ID: 19735853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Varenicline in the management of smoking cessation: a single technology appraisal.
    Hind D; Tappenden P; Peters J; Kenjegalieva K
    Health Technol Assess; 2009 Sep; 13 Suppl 2():9-13. PubMed ID: 19804684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-nicotine pharmacotherapies for smoking cessation.
    McRobbie H; Lee M; Juniper Z
    Respir Med; 2005 Oct; 99(10):1203-12. PubMed ID: 16011894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of COPD smokers and effectiveness and safety of smoking cessation medications.
    Jiménez Ruiz CA; Ramos Pinedo A; Cicero Guerrero A; Mayayo Ulibarri M; Cristobal Fernández M; Lopez Gonzalez G
    Nicotine Tob Res; 2012 Sep; 14(9):1035-9. PubMed ID: 22345320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Inquiry: which smoking cessation interventions work best?
    Mahvan T; Namdar R; Voorhees K; Smith PC; Ackerman W
    J Fam Pract; 2011 Jul; 60(7):430-1. PubMed ID: 21731922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drugs to support smoking cessation in UK general practice: are evidence based guidelines being followed?
    Wilson A; Sinfield P; Rodgers S; Hammersley V; Coleman T
    Qual Saf Health Care; 2006 Aug; 15(4):284-8. PubMed ID: 16885254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Zealand smoking cessation guidelines.
    McRobbie H; Bullen C; Glover M; Whittaker R; Wallace-Bell M; Fraser T;
    N Z Med J; 2008 Jun; 121(1276):57-70. PubMed ID: 18574510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smoking cessation 1: pharmacological treatments.
    Cofta-Woerpel L; Wright KL; Wetter DW
    Behav Med; 2006; 32(2):47-56. PubMed ID: 16903614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Did the introduction of varenicline in England substitute for or add to the use of other smoking cessation medications?
    Kotz D; Fidler JA; West R
    Nicotine Tob Res; 2011 Sep; 13(9):793-9. PubMed ID: 21543548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smoking cessation guidelines: evidence-based recommendations of the French Health Products Safety Agency.
    Le Foll B; Melihan-Cheinin P; Rostoker G; Lagrue G;
    Eur Psychiatry; 2005 Aug; 20(5-6):431-41. PubMed ID: 16171657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The STOP Program: a Hybrid Smoking Prevention and Cessation Training for Cancer Care Providers in Colombia and Peru.
    Tamí-Maury I; Tundealao S; Díaz V; Ochoa E; Garcia E; Rincon J; Noé-Díaz V; Castañeda C; Acosta J; Fernández M; Vidaurre T; Crowley J
    J Cancer Educ; 2023 Oct; 38(5):1683-1689. PubMed ID: 37368119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.